Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1974 1
1976 1
1978 1
1979 3
1981 1
1985 1
1986 2
1988 1
1991 1
1992 2
1995 1
2000 1
2002 1
2005 1
2009 2
2010 2
2011 4
2012 4
2013 3
2014 2
2015 3
2016 2
2017 2
2018 3
2019 2
2020 3
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohort.
Nguyen-Khac E, Nahon P, Ganry O, Ben Khadhra H, Merle P, Amaddeo G, Ganne-Carrie N, Silvain C, Peron JM, Mathurin P, Anty R, Uguen T, Decaens T, Riachi G, Bouattour M, Baron A, Bronowicki JP, Pageaux GP, Rosmorduc O, Ducournau G, Gilberg M, Tanang A, Dupin J, Gilbert-Marceau A, Blanc JF; French CHIEF cohort group. Nguyen-Khac E, et al. Among authors: dupin j. Eur J Gastroenterol Hepatol. 2023 Oct 1;35(10):1168-1177. doi: 10.1097/MEG.0000000000002546. Epub 2023 Aug 11. Eur J Gastroenterol Hepatol. 2023. PMID: 37577805
Thrombolysis by thienopyridines and their congeners.
Gryglewski RJ, Dupin JP, Uracz W, Swiês J, Madej J, Hou G, Gravier D, Casadebaig F. Gryglewski RJ, et al. Among authors: dupin jp. J Physiol Pharmacol. 2000 Dec;51(4 Pt 1):683-93. J Physiol Pharmacol. 2000. PMID: 11192941 Free article.
Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database.
Tredan O, Laurent M, Gilberg M, Ghorbal R, Vainchtock A, Lortet-Tieulent J, Prodel M, Dupin J. Tredan O, et al. Among authors: dupin j. Cancer Inform. 2022 Nov 9;21:11769351221135134. doi: 10.1177/11769351221135134. eCollection 2022. Cancer Inform. 2022. PMID: 36386278 Free PMC article.
Long Terms Follow-Up of the Randomized MetaspHER Study Comparing Intravenous Versus Subcutaneous Trastuzumab in Patients' With HER2-Positive Metastatic Breast Cancer.
Pivot X, Spano JP, Espie M, Jouannaud C, Pottier V, Moreau L, Extra JM, Lortholary A, Rivera P, Spaeth D, Mouri Z, Tariket F, Dupin J, Berthois A, Ionescu-Goga M, Ferhat A, Cottu P, Gligorov J. Pivot X, et al. Among authors: dupin j. Clin Breast Cancer. 2023 Oct;23(7):e412-e419. doi: 10.1016/j.clbc.2023.06.007. Epub 2023 Jun 20. Clin Breast Cancer. 2023. PMID: 37423801
49 results